Nkilt Therapeutics
Biotechnology, 266 Northview Ter, Houston, Texas, 07081, United States, 1-10 Employees
Who is NKILT THERAPEUTICS
NKILT Therapeutics, Inc., is a new cell therapy biotech developing a novel approach of engineering Natural Killer (NK) cells, and other immune cells, to directly target leukemias and soli...
Read More
-
Headquarters: 266 Northview Ter, Houston, Texas, 07081, United States
-
Date Founded: 2021
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
Does something look wrong? Fix it. | View contact records from NKILT THERAPEUTICS
NKILT Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding NKILT Therapeutics
Answer: NKILT Therapeutics's headquarters are located at 266 Northview Ter, Houston, Texas, 07081, United States
Answer: NKILT Therapeutics's official website is https://nkilt.com
Answer: NKILT Therapeutics's revenue is Under $1 Million
Answer: NKILT Therapeutics has 1-10 employees
Answer: NKILT Therapeutics is in Biotechnology
Answer: NKILT Therapeutics contact info: Phone number: Website: https://nkilt.com
Answer: NKILT Therapeutics, Inc., is a new cell therapy biotech developing a novel approach of engineering Natural Killer (NK) cells, and other immune cells, to directly target leukemias and solid tumors. We have In vitro PoC confirmed with T cells and NK cells. Our approach is based on the novel Chimeric ILT-Receptor (CIRTM), featuring a unique proprietary binding technology, targeting the inducible immune checkpoint, HLA-G (expressed in over 50% of human cancers). Our initial armored CIRTMNK cells will be able to exquisitely target and directly kill cancer cells but will also activate innate immunity and directly target the tumors defense mechanisms. The first indication will be Acute Myeloid Leukemia (AML) as a pre-clinical/clinical proof of concept, while our core focus is to expand to a large array of solid tumors such as Colorectal Cancer (CRC), Ovarian Cancer, Renal Cell Carcinoma (RCC), Endometrial Cancer, and more HLA-G+ tumors.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month